Filamin-A links transcriptional disruption to dopaminergic decline in progressive supranuclear palsy
Brain · 19.10.2026
DOI: 10.1093/brain/awag228 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, online erschienen am 19.10.2026. Verfasst von Koyo Tsujikawa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Rare Disease Genome Centre, Nagoya University, Nagoya 464-8601, Japan. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS, KAKENHI, AMED.
Abstract (Originalsprache)
Progressive supranuclear palsy is a late-onset neurodegenerative disorder characterized by tau aggregation and prominent dopaminergic dysfunction, yet the upstream molecular processes linking transcriptional abnormalities to dopaminergic failure remain poorly understood. To explore these mechanisms, we performed an integrated multi-omics analysis using a mouse model with overexpression of human filamin-A, a cytoskeletal protein genetically implicated in progressive supranuclear palsy. Analyses were conducted in young adult mice (5–7 months) and aged mice (14–16 months) of both sexes, with transcriptomic, epigenomic, biochemical, metabolomic and behavioural profiling performed across multiple brain regions. In parallel, post-mortem human brain tissue from 11 individuals with progressive supranuclear palsy and five neurologically normal controls was analysed for biochemical validation using samples from the frontal cortex and striatum. Transcriptomic profiling identified immediate early gene-centred transcriptional dysregulation as a prominent and early molecular alteration. This change, accompanied by chromatin accessibility alterations, was associated with the activation of activator protein 1-dependent gene programmes and region-specific changes in dopaminergic protein markers across the cortex, striatum and midbrain. Multi-layered analyses revealed cortical monoamine depletion together with early striatal dopaminergic sensitization, indicating a close association between immediate early gene dysregulation and dopaminergic circuit imbalance. With ageing, the coupling was lost, coinciding with dopaminergic exhaustion and deficits in locomotor, cognitive and social behaviours. In human analyses, post-mortem brain samples from individuals with progressive supranuclear palsy showed reduced dopamine D2 receptor expression compared with neurologically normal controls, together with region-dependent alterations in c-Fos expression and enrichment of activator protein 1-related motifs in regions with reduced chromatin accessibility. Together, these findings suggest that filamin-A-dependent cytoskeletal stress acts as an upstream molecular context in which immediate early gene-centred transcriptional dysregulation emerges and becomes linked to dopaminergic vulnerability in progressive supranuclear palsy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rare Disease Genome Centre, Nagoya University, Nagoya 464-8601, Japan.
- Department of Genetics, Research Institute of Environmental Medicine (RIeM), Nagoya University, Nagoya 464-8601, Japan.
- Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
- Department of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, Nagakute 480-1195, Japan.
Förderung
- JSPS
- KAKENHI
- AMED
- Tokai Pathways to Global Excellence
Zitieren
APA
Tsujikawa, K., Sahashi, K., Ito, S., Maekawa, T., Riku, Y., Iwasaki, Y., Ogi, T., & Katsuno, M. (2026). Filamin-A links transcriptional disruption to dopaminergic decline in progressive supranuclear palsy. Brain. https://doi.org/10.1093/brain/awag228
Vancouver
Tsujikawa K, Sahashi K, Ito S, Maekawa T, Riku Y, Iwasaki Y, et al. Filamin-A links transcriptional disruption to dopaminergic decline in progressive supranuclear palsy. Brain. 2026. doi:10.1093/brain/awag228
BibTeX
@article{Tsujikawa2026,
author = {Tsujikawa, Koyo and Sahashi, Kentaro and Ito, Shota and Maekawa, Tomoya and Riku, Yuichi and Iwasaki, Yasushi and Ogi, Tomoo and Katsuno, Masahisa},
title = {Filamin-A links transcriptional disruption to dopaminergic decline in progressive supranuclear palsy},
journal = {Brain},
year = {2026},
doi = {10.1093/brain/awag228}
}
EUVIMED